Anti-PD-L1 antibodies and uses thereof

US10889648B2 · kind B2 · utility

Assignee

• JIANGSU HYAMAB PHARMACEUTICAL CO., LTD. · CN

Inventors

• Lile LIU · Shanghai, CN
• Xinxiu YANG · Shanghai, CN
• Haishan LUO · Shanghai, CN
• Zhengrong SHUAI · Shanghai, CN
• Hu Liu · Beijing, CN
• Shaoping HU · Shanghai, CN
• Xiaolan Sun · Shanghai, CN
• Hongzhuan GU · Shanghai, CN
• Qing DUAN · Shanghai, CN
• Tatchi Teddy YANG · Shanghai, CN

Key dates

• Filing date: Dec 27, 2016
• Grant date: Jan 12, 2021
• Expiry date: Dec 6, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/94
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are anti-PD-L1 antibodies and antigen-binding fragments thereof. Also provided are nucleic acids encoding the antibodies, compositions containing the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, infectious diseases and autoimmune diseases.